Whitfield Dianne C.
Insider CIK 1839516 · TARS Chief Human Resources Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-19 | 2026-03-19 | 4,174 | $67.00 | $279.7K | 35,028 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-18 | 2026-03-19 | 4,071 | $68.71 | $279.7K | 39,202 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-17 | 2026-03-19 | 4,029 | $69.42 | $279.7K | 43,273 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 5,022 | — | $0 | 15,067 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 4,463 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 7,248 | — | $0 | 7,249 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 7,176 | — | $0 | 14,351 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-03-15 | 2026-03-17 | 23,909 | — | $0 | 47,302 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 17,161 | — | $0 | 17,161 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 27,310 | — | $0 | 27,310 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-01-02 | 2026-01-06 | 5,715 | $80.09 | $457.7K | 33,243 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-01-02 | 2026-01-06 | 8,122 | $80.71 | $655.5K | 25,121 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-01-02 | 2026-01-06 | 893 | $82.93 | $74.1K | 23,393 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-01-02 | 2026-01-06 | 835 | $81.90 | $68.4K | 24,286 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-16 | 2025-12-18 | 7,397 | $80.10 | $592.5K | 38,958 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-20 | 2025-03-20 | 2,137 | $50.11 | $107.1K | 46,355 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-19 | 2025-03-20 | 2,259 | $47.40 | $107.1K | 48,492 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-18 | 2025-03-20 | 2,315 | $46.29 | $107.2K | 50,751 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 7,248 | — | $0 | 14,497 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 7,175 | — | $0 | 21,527 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 4,462 | — | $0 | 4,463 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-03-15 | 2025-03-18 | 18,885 | — | $0 | 53,066 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 20,089 | — | $0 | 20,089 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 30,628 | — | $0 | 30,628 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2024-03-18 | 2024-03-19 | 4,314 | $30.60 | $132.0K | 34,181 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 7,248 | — | $0 | 21,745 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 4,463 | — | $0 | 8,925 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-03-15 | 2024-03-19 | 11,711 | — | $0 | 38,495 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 28,702 | — | $0 | 28,702 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 42,500 | — | $0 | 42,500 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-11-30 | 2023-12-01 | 8,355 | $16.31 | $136.3K | 26,784 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-11-29 | 2023-12-01 | 23,920 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-11-29 | 2023-12-01 | 23,920 | — | $0 | 35,139 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-23 | 2023-03-23 | 345 | $12.15 | $4.2K | 11,219 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-22 | 2023-03-23 | 333 | $12.64 | $4.2K | 11,564 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-21 | 2023-03-23 | 326 | $12.89 | $4.2K | 11,897 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-20 | 2023-03-21 | 333 | $12.61 | $4.2K | 12,223 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-17 | 2023-03-21 | 316 | $13.28 | $4.2K | 12,556 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-17 | 313 | $13.43 | $4.2K | 12,872 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-03-15 | 2023-03-17 | 4,462 | — | $0 | 13,388 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-03-15 | 2023-03-17 | 4,462 | — | $0 | 13,185 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 42,802 | — | $0 | 42,802 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 28,993 | — | $0 | 28,993 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-02 | 2022-12-06 | 1,154 | $16.90 | $19.5K | 8,723 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-01 | 2022-12-01 | 1,165 | $16.75 | $19.5K | 9,877 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-11-30 | 2022-12-01 | 1,182 | $16.50 | $19.5K | 11,042 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2022-11-29 | 2022-12-01 | 10,251 | — | $0 | 23,920 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2022-11-29 | 2022-12-01 | 10,251 | — | $0 | 12,224 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 60,846 | — | $0 | 60,846 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 17,850 | — | $0 | 17,850 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 34,171 | — | $0 | 34,171 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-01-07 | 2021-01-08 | 89,368 | — | $0 | 89,368 | SEC↗ |